The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Adlai Nortye Biopharma Co., Ltd.
AN0025 in combination with definitive chemoradiotherapy (dCRT) in unresectable locally advanced or locally recurrent esophageal cancer (EC): A single-arm, open-label, multicenter, phase Ib study.
 
Nan Bi
No Relationships to Disclose
 
Fang Liu
No Relationships to Disclose
 
Ying Hu
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Wenyang Liu
No Relationships to Disclose
 
Rongrui Liu
No Relationships to Disclose
 
Yanli Liu
No Relationships to Disclose
 
Pei Zhang
No Relationships to Disclose
 
Chuan Hua Zhao
No Relationships to Disclose
 
Jing Chen
No Relationships to Disclose
 
Lingrong Luo
No Relationships to Disclose
 
Zaijie Huang
No Relationships to Disclose
 
Mengjie Gu
Employment - Adlai Nortye Biopharma Co., Ltd.
 
Kaiyang Tang
Employment - Adlai Nortye Biopharma Co., Ltd.
Leadership - Adlai Nortye Biopharma Co., Ltd.
Stock and Other Ownership Interests - Adlai Nortye Biopharma Co., Ltd.
 
Xuyang Lu
Employment - Adlai Nortye Biopharma Co., Ltd.
Stock and Other Ownership Interests - Adlai Nortye Biopharma Co., Ltd.
 
Xuyang Song
Employment - Adlai Nortye Biopharma Co., Ltd.
Stock and Other Ownership Interests - Adlai Nortye Biopharma Co., Ltd.
 
Tianyi Zhao
No Relationships to Disclose
 
Yuan Wang
Employment - Adlai Nortye Biopharma Co., Ltd.
 
Hongming Liang
Employment - Adlai Nortye Biopharma Co., Ltd.
 
Jianming Xu
No Relationships to Disclose